Table 1 Demographics

N (male/female)^a

30/16

13/22

25/14

15/16

Age at sampling (years), mean (SD)^b

64.46 (11.5)

63.48 (7.8)

69.77 (5.1)

45.48 (17.7)

Disease duration at puncture (months), mean (SD)^b

83.78 (45.9)

63.51 (23.8)

54.8 (28.4)

–

Follow-up time (months), mean (SD)^b

11.3 (9.2)

18.2 (16.5)

18.9 (14.6)

–

H + Y stages, median, IQR

2 (2)

3 (1)

3 (1)

–

Comorbidity, Charlson score (age-adjusted)

0.81

0.63

1.10

0.60

Levodopa Dose Equivalents, mg, SD^b

596.8 (382.6)

712.28 (552.7)

324.2 (369.0)

–